$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000110465913081206 Filed on November 05, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$13.96M	$13.09M	$12.69M
YoY Change	7.42%	3.19%	5.95%
Cost Of Revenue	$11.90M	$11.46M	$11.04M
YoY Change	5.37%	3.78%	4.18%
Gross Profit	$2.060M	$1.633M	$1.646M
YoY Change	21.01%	-0.77%	19.6%
Gross Profit Margin	14.75%	12.47%	12.97%
Selling, General & Admin	$3.795M	$3.386M	$3.325M
YoY Change	4.4%	1.83%	46.41%
% of Gross Profit	184.25%	207.34%	202.04%
Research & Development	$5.794M	$10.61M	$16.24M
YoY Change	-50.7%	-34.65%	284.7%
% of Gross Profit	281.26%	649.69%	986.58%
Depreciation & Amortization	$260.0K	$250.0K	$270.0K
YoY Change	0.0%	-7.41%	-3.57%
% of Gross Profit	12.62%	15.31%	16.4%
Operating Expenses	$9.589M	$14.00M	$19.56M
YoY Change	-37.68%	-28.45%	201.33%
Operating Profit	-$7.529M	-$12.36M	-$17.92M
YoY Change	-44.98%	-30.99%	250.21%
Interest Expense	-$800.0K	-$840.0K	$40.00K
YoY Change	-8100.0%	-2200.0%	-50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$8.332M	-$13.21M	-$17.88M
YoY Change	-39.06%	-26.11%	254.71%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$8.332M	-$13.21M	-$17.88M
YoY Change	-39.06%	-26.11%	254.57%
Net Earnings / Revenue	-59.67%	-100.87%	-140.87%
Basic Earnings Per Share		-$0.34	-$0.86
Diluted Earnings Per Share	-$210.5K	-$0.34	-$0.86
COMMON SHARES
Basic Shares Outstanding	40.00M shares	39.33M shares	20.73M shares
Diluted Shares Outstanding		39.33M shares	20.73M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$23.92M	$31.22M	$11.25M
YoY Change	407.86%	177.51%	-44.42%
Cash & Equivalents	$11.88M	$21.21M	$1.174M
Short-Term Investments	$12.03M	$10.00M	$10.08M
Other Short-Term Assets	$623.7K	$687.4K	$1.760M
YoY Change	-54.01%	-60.95%	28.47%
Inventory	$2.800M	$2.810M	$2.670M
Prepaid Expenses
Receivables	$4.578M	$4.222M	$4.320M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$31.92M	$38.94M	$20.00M
YoY Change	142.73%	94.71%	-28.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.649M	$1.705M	$1.940M
YoY Change	-11.27%	-12.1%	-21.14%
Goodwill	$920.7K	$920.7K
YoY Change	0.0%
Intangibles	$499.7K	$541.5K
YoY Change	-25.05%
Long-Term Investments
YoY Change
Other Assets	$1.375M	$1.492M	$650.0K
YoY Change	219.96%	129.57%	-71.37%
Total Long-Term Assets	$4.444M	$4.660M	$4.220M
YoY Change	14.67%	10.42%	-34.98%
TOTAL ASSETS
Total Short-Term Assets	$31.92M	$38.94M	$20.00M
Total Long-Term Assets	$4.444M	$4.660M	$4.220M
Total Assets	$36.36M	$43.60M	$24.22M
YoY Change	113.58%	80.02%	-29.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.686M	$7.112M	$8.090M
YoY Change	-41.44%	-12.09%	124.1%
Accrued Expenses	$6.648M	$10.12M	$14.69M
YoY Change	-44.68%	-31.08%	149.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$570.0K	$0.00
YoY Change
Long-Term Debt Due	$2.308M	$571.4K	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$17.85M	$18.07M	$23.05M
YoY Change	-33.86%	-21.6%	139.6%
LONG-TERM LIABILITIES
Long-Term Debt	$17.92M	$19.43M	$0.00
YoY Change
Other Long-Term Liabilities	$17.92M	$19.43M
YoY Change
Total Long-Term Liabilities	$17.92M	$19.43M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.85M	$18.07M	$23.05M
Total Long-Term Liabilities	$17.92M	$19.43M	$0.00
Total Liabilities	$35.77M	$37.50M	$23.05M
YoY Change	32.52%	62.69%	139.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$158.8M	-$150.5M
YoY Change	44.35%
Common Stock	$154.5M	$151.4M
YoY Change	66.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$595.5K	$6.101M	$1.170M
YoY Change
Total Liabilities & Shareholders Equity	$36.36M	$43.60M	$24.22M
YoY Change	113.58%	80.02%	-29.98%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$8.332M	-$13.21M	-$17.88M
YoY Change	-39.06%	-26.11%	254.57%
Depreciation, Depletion And Amortization	$260.0K	$250.0K	$270.0K
YoY Change	0.0%	-7.41%	-3.57%
Cash From Operating Activities	-$8.140M	-$9.690M	-$8.790M
YoY Change	13.53%	10.24%	283.84%
INVESTING ACTIVITIES
Capital Expenditures	-$150.0K	-$190.0K	-$690.0K
YoY Change	-135.71%	-72.46%	146.43%
Acquisitions
YoY Change
Other Investing Activities	-$2.010M	-$10.00M	$3.990M
YoY Change	-120.02%	-350.63%	2750.0%
Cash From Investing Activities	-$2.160M	-$10.18M	$3.300M
YoY Change	-120.65%	-408.48%	-2457.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	970.0K	130.0K	200.0K
YoY Change	304.17%	-35.0%	-87.01%
NET CHANGE
Cash From Operating Activities	-8.140M	-9.690M	-8.790M
Cash From Investing Activities	-2.160M	-10.18M	3.300M
Cash From Financing Activities	970.0K	130.0K	200.0K
Net Change In Cash	-9.330M	-19.74M	-5.290M
YoY Change	-364.31%	273.16%	494.38%
FREE CASH FLOW
Cash From Operating Activities	-$8.140M	-$9.690M	-$8.790M
Capital Expenditures	-$150.0K	-$190.0K	-$690.0K
Free Cash Flow	-$7.990M	-$9.500M	-$8.100M
YoY Change	5.27%	17.28%	302.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.99
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.99
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36520393	USD
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39327994	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20726967	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39327994	shares
CY2013Q3	rmti	Manufacturing And Distribution Us Facilities Number ManufacturingAndDistributionUSFacilitiesNumber	3	facilities
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33588458	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30652944	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20244518	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20726967	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30652944	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20244518	shares
CY2013Q3	us-gaap	Assets Current AssetsCurrent	38941712	USD
CY2013Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	215613	USD
CY2013Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1512758	USD
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2013Q3	us-gaap	Assets Assets	43601401	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	18071690	USD
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.32
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1018648	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	179922	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1451069	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	2649639	USD
CY2013Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1085794	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1109776	USD
	dei	Entity Registrant Name EntityRegistrantName	ROCKWELL MEDICAL, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001041024
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39997961	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4711730	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4431932	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1356131	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	13149432	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1858442	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	666744	USD
CY2012Q4	us-gaap	Goodwill Goodwill	920745	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2280	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14833565	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12015978	USD
CY2012Q4	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	135133	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26986956	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	92866458	USD
CY2012Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7178929	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-110007257	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-9961870	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17025086	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	6101066	USD
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-846	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40348027	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43601401	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19428645	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	26000	USD
CY2012Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21494696	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21494696	shares
CY2012Q4	rmti	Common Share Warrants Issued CommonShareWarrantsIssued	2233240	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2233240	shares
CY2013Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2013Q3	rmti	Common Share Warrants Issued CommonShareWarrantsIssued	1063071	shares
CY2013Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1063071	shares
CY2012Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	12689339	USD
CY2012Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	11043412	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	1645927	USD
CY2012Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3325411	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16238450	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17917934	USD
CY2012Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	42296	USD
CY2012Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-137	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17875775	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-17875775	USD
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	36842546	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	31851344	USD
	us-gaap	Gross Profit GrossProfit	4991202	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9048474	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-40577665	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	230484	USD
	us-gaap	Net Income Loss NetIncomeLoss	-40348027	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	148907	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	254069	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13203932	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17726868	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40446875	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-40093958	USD
	rmti	Issuance Of Stock And Warrants And Other Equity Based Compensation For Services Or Claims IssuanceOfStockAndWarrantsAndOtherEquityBasedCompensationForServicesOrClaims	1435344	USD
	us-gaap	Net Income Loss NetIncomeLoss	-40451207	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50260374	USD
	rmti	Stock Issued During Period Value In Exchange For Services StockIssuedDuringPeriodValueInExchangeForServices	392000	USD
	rmti	Stock Issued During Period Value Purchase Warrant Expense StockIssuedDuringPeriodValuePurchaseWarrantExpense	1043344	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	-364981	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3026933	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1422179	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	828676	USD
	rmti	Issuance Of Stock And Warrants And Other Equity Based Compensation For Services Or Claims IssuanceOfStockAndWarrantsAndOtherEquityBasedCompensationForServicesOrClaims	1309502	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	95917	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	167940	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1233592	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2726145	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	7184330	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-10880210	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23576075	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	381400	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1578	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1056928	USD
	rmti	Proceeds From Issuance Of Common Shares And Purchase Warrants ProceedsFromIssuanceOfCommonSharesAndPurchaseWarrants	17983844	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	20000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4540975	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17978172	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	69513301	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10490015	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42522190	USD
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	5672	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5715246	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1174271	USD
	us-gaap	Interest Paid InterestPaid	846	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10611219	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4222411	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1705258	USD
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	541472	USD
CY2013Q3	us-gaap	Goodwill Goodwill	920745	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1492214	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7111561	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10124949	USD
CY2013Q3	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	263825	USD
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	2280	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	16501096	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	550000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3986750	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-606263	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7722004	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2079489	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	9150235	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	496302	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6898	USD
	rmti	Proceeds From Issuance Of Common Shares And Purchase Warrants ProceedsFromIssuanceOfCommonSharesAndPurchaseWarrants	50625357	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4332	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	151396640	USD
CY2013Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5158558	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150458464	USD
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	13094381	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	38414919	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	11461100	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	33815593	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	1633281	USD
	us-gaap	Gross Profit GrossProfit	4599326	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3386367	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10541124	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12364305	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39530256	USD
CY2013Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	13546	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	28784	USD
CY2013Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-857505	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-949735	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4332	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13208264	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40451207	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-13208264	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4449110	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-15500	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-209521	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	164526	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Interest Paid InterestPaid	522797	USD
CY2013Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	10004943	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4332	USD
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	687367	USD
CY2013Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	571355	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	10000611	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	0	USD
	rmti	Noncash Interest Expense NoncashInterestExpense	426938	USD
CY2013Q3	rmti	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	6338	USD
CY2013Q3	rmti	Available For Sale Securities Gross Unrealized Loss Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	2006	USD

Files In Submission

Name	View Source	Status
0001104659-13-081206-index-headers.html	Edgar Link	pending
0001104659-13-081206-index.html	Edgar Link	pending
0001104659-13-081206.txt	Edgar Link	pending
0001104659-13-081206-xbrl.zip	Edgar Link	pending
a13-19818_110q.htm	Edgar Link	pending
a13-19818_1ex31d1.htm	Edgar Link	pending
a13-19818_1ex31d2.htm	Edgar Link	pending
a13-19818_1ex32d1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmti-20130930.xml	Edgar Link	completed
rmti-20130930.xsd	Edgar Link	pending
rmti-20130930_cal.xml	Edgar Link	unprocessable
rmti-20130930_def.xml	Edgar Link	unprocessable
rmti-20130930_lab.xml	Edgar Link	unprocessable
rmti-20130930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2013 Q4 Form 10-Q Financial Statement

#000110465913081206 Filed on November 05, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2013 Q4 Form 10-Q Financial Statement

#000110465913081206 Filed on November 05, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti